Cognitive Alterations in Pulmonary Arterial Hypertension (PAH)

计划入组 30 人 · 首次发布于 2026 年 2 月 5 日

Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)

计划入组 3 人 · 首次发布于 2021 年 7 月 20 日

Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

计划入组 8 人 · 首次发布于 2018 年 8 月 20 日

Iloprost(Ventavis)

C₂₂H₃₂O₄ · Rx

agonist antibody (pulmonary arterial hypertension)

PDE10 inhibitors (Pulmonary Arterial Hypertension)

Kidney & Hypertension Center

United States

PULMONARY HOMECARE

United States

Shanghai Institute of Hypertension

China

Liquidia's Yutrepia Receives Tentative FDA Approval for Pulmonary Hypertension

Inhibikase Therapeutics Secures $275M Financing, Advances IkT-001Pro for Pulmonary Arterial Hypertension

Cereno Scientific Secures Funding to Advance Pulmonary Hypertension and Fibrosis Programs